Markus Müschen, MD, PhD
Biography
Research & Publications
News
Locations
Appointments
Biography
Dr. Markus Müschen is the Arthur H. and Isabel Bunker Professor of Hematology, HHMI Faculty Scholar and was appointed Director of the Center of Molecular and Cellular Oncology at Yale in October 2020. He obtained his MD degree in Biochemistry with Helmut Sies (summa cum laude) from the Heinrich-Heine-Universität in Düsseldorf, completed his residency in Hematology-Oncology with Volker Diehl and his MD-PhD with Martin Krönke in Immunology at the University of Cologne, Germany. Since 2009, the Müschen laboratory has established new conceptual frameworks for the understanding of B-cell signaling and energy metabolism and how defects in these mechanisms contribute to autoimmunity and B-cell transformation. Influenced by his postdoctoral training in basic immunology (Klaus Rajewsky and Ralf Küppers) and cancer genetics (Janet D. Rowley), Dr. Müschen is particularly interested in signal transduction pathways that change the clinical trajectory of human B-cell malignancies and B-cell driven autoimmune diseases.
Education & Training
- Visiting Assistant ProfessorChildren's Hospital Los Angeles and University of Southern California (2009)
- Residency and FellowshipUniversity of Cologne (2006)
- PhDInstitute for Genetics Cologne, Immunology (2003)
- Postdoctoral fellowshipUniversity of Chicago (2002)
- Postdoctoral fellowshipInstitute for Genetics, University of Cologne (2000)
- MDHeinrich-Heine-Universität Düsseldorf, Biochemistry (1999)
Honors & Recognition
Award | Awarding Organization | Date |
---|---|---|
NCI Outstanding Investigator Award 2021 | National Cancer Institute | 2021 |
Elected Member, ASCI | American Society of Clinical Investigation | 2019 |
18th Annual Maxwell M. Wintrobe Endowed Lecture | University of Utah | 2018 |
Stephen D. Williams, MD, Lectureship | Indiana University | 2018 |
20th Andrew I. Schafer Distinguished Lecture | Cornell University | 2018 |
Norman and Sadie Lee Foundation Endowed Chair | Norman and Sadie Lee Foundation | 2017 |
NCI Outstanding Investigator Award (R35) | National Cancer Institute | 2016 |
Howard Hughes Medical Institute Faculty Scholar Award | Howard Hughes Medical Institute | 2016 |
Cancer Research UK Programme Award | Cancer Research UK | 2014 |
Honorary faculty appointment | Cambridge University | 2014 |
Wellcome Trust Senior Investigator Award | Wellcome Trust | 2013 |
Sir Alexander Haddow Professorship | The Institute for Cancer Research (ICR) | 2012 |
Scholar Award | Leukemia and Lymphoma Society | 2011 |
Stand Up To Cancer Innovation | American Association for Cancer Research | 2009 |
Leukemia Clinical Research Award | German Society of Hematology and Oncology | 2006 |
Fritz-Melchers-Award in Immunology | German Association of Immunologists | 2003 |
Emmy-Noether-Award | German Science Foundation (DFG) | 2002 |
Irvington Postdoctoral Fellowship Award | Cancer Research Institute | 2000 |
Professional Service
Organization | Role | Date |
---|---|---|
Scientific Advisory Board, The Blood Research Institute, Milwaukee, WI | Member | 2021 - Present |
Hôpital Necker-Enfants Malades Scientific Advisory Board, Hôpital Necker-Enfants Malades | Scientific Advisor | 2018 - Present |
NIH Molecular Oncogenesis (MONC) study section | Member | 2016 - Present |
Biological Chemistry | Associate Editor | 2009 - Present |
Leukemia, Nature Publishing Group | Associate Editor | 2008 - 2014 |